Craig Waggy

Skyhook accelerates the discovery and development of transformative therapies by enabling access to previously uncharted biological design spaces. Our revolutionary platform integrates efficient computational (AI/ML) design, synthesis, and functional screening of diverse programmable biomolecule libraries at unprecedented speed and scale. Skyhook is an RA Ventures* company. *RA Ventures is the venture focused division of RA Capital Management.